AI assistant
Catheter Precision, Inc. — Director's Dealing 2021
Feb 6, 2021
35479_dirs_2021-02-05_595dd909-f2b9-4995-a269-1701a16fea1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ra Medical Systems, Inc. (RMED)
CIK: 0001716621
Period of Report: 2021-02-03
Reporting Person: Meline Susanne (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-03 | Common Stock | A | 4000 | $0.00 | Acquired | 5808 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 40000 | Indirect |
Footnotes
F1: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. The RSUs shall vest annually over a four year period, beginning on January 31, 2021, so that the RSUs will be fully vested on January 31, 2025, subject to the reporting person's continued service through each such vesting date.
F2: Securities are owned by Catalysis Partners ("CP"). The reporting person has an investment interest in CP through her IRA and, together with an immediate family member, owns a controlling interest in Francis Capital Management, LLC, which also has an investment interest in CP and serves as both its Managing Member and Investment Manager. The reporting person disclaims beneficial interest of these securities except to the extent of her pecuniary interest therein.